Principal Investigator: Corina Dunlap ND, MS
Abstract: Polycystic ovary syndrome (PCOS) is a common endocrine syndrome that affects women of reproductive age. It is characterized by irregular menses or amenorrhea, signs of androgen excess (e.g., acne, hirsutism, male-pattern hair loss), and in some women, multiple ovarian cysts. Concomitant morbidities can include infertility, increased risk for type 2 diabetes, mood disorders, and cardiovascular disease risk factors such as obesity, dyslipidemia, and metabolic syndrome. Evidence suggests that treatment with certain micronutrients may have a positive impact on PCOS comorbidities. Such micronutrients include B vitamins, folate, magnesium, selenium, zinc, and alpha-tocopherol. Alterations in carbohydrate amount and type, as well as dietary fatty acids, have also been shown to have a positive impact within this population group. This study will assess the impact of a custom-designed, nutritionally dense dietary supplement named UltraGlucose Control (UGC), in addition to a comprehensive diet and lifestyle education program, on nutritional status and quality of life in women with Polycystic Ovary Syndrome (PCOS).